SXTP CIK: 1946563

60 Degrees Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.31
FY22:
−0.21
FY23:
−0.22
FY24:
0.22
FY25:
0.22
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.12
FY22:
−2.04
FY23:
−5.15
FY24:
−9.79
FY25:
−8.16
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.01
FY22:
−1.71
FY23:
0.24
FY24:
–
FY25:
−7.54
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.26
FY22:
−6.18
FY23:
−3.81
FY24:
−7.96
FY25:
−7.37
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.25
FY22:
−6.18
FY23:
−3.77
FY24:
−7.95
FY25:
−7.37

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data